Genome Diagnostics Ltd

DataGardener
live
Micro

Genome Diagnostics Ltd

ni667396Private Limited With Share Capital

C/O Qubis Ltd, 63 University Road, Belfast, BT71NF
Incorporated

31/01/2020

Company Age

6 years

Directors

4

Employees

4

SIC Code

72110

Risk

low risk

Company Overview

Registration, classification & business activity

Genome Diagnostics Ltd (ni667396) is a private limited with share capital incorporated on 31/01/2020 (6 years old) and registered in belfast, BT71NF. The company operates under SIC code 72110 and is classified as Micro.

Genome diagnostics is a new spinout from the prestigious patrick g johnston centre for cancer research at queen’s university belfast. we are developing a novel blood test for earlier and more accurate diagnosis of ovarian cancer and to improve upon the accuracy of the current gold standard ovarian c...

Private Limited With Share Capital
SIC: 72110
Micro
Incorporated 31/01/2020
BT71NF
4 employees

Financial Overview

Total Assets

£852.3K

Liabilities

£32.9K

Net Assets

£819.4K

Est. Turnover

£3.19M

AI Estimated
Unreported
Cash

£0

Key Metrics

4

Employees

4

Directors

9

Shareholders

1

PSCs

Board of Directors

4

Filed Documents

36
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:26-02-2026
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:29-10-2025
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:04-03-2025
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:25-10-2024
Confirmation Statement With Updates
Category:Confirmation Statement
Date:05-03-2024
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:31-10-2023
Resolution
Category:Resolution
Date:13-09-2023
Capital Allotment Shares
Category:Capital
Date:22-05-2023
Capital Allotment Shares
Category:Capital
Date:24-04-2023
Capital Allotment Shares
Category:Capital
Date:17-04-2023
Capital Allotment Shares
Category:Capital
Date:21-03-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:20-02-2023
Resolution
Category:Resolution
Date:16-02-2023
Capital Allotment Shares
Category:Capital
Date:16-02-2023
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:31-10-2022
Appoint Person Director Company With Name Date
Category:Officers
Date:13-06-2022
Appoint Person Director Company With Name Date
Category:Officers
Date:13-06-2022
Confirmation Statement With Updates
Category:Confirmation Statement
Date:21-03-2022
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:28-10-2021
Resolution
Category:Resolution
Date:10-03-2021
Resolution
Category:Resolution
Date:10-03-2021
Confirmation Statement With Updates
Category:Confirmation Statement
Date:08-03-2021
Appoint Person Director Company With Name Date
Category:Officers
Date:08-03-2021
Capital Allotment Shares
Category:Capital
Date:08-03-2021
Termination Director Company With Name Termination Date
Category:Officers
Date:25-02-2021
Termination Director Company With Name Termination Date
Category:Officers
Date:19-02-2021
Confirmation Statement With Updates
Category:Confirmation Statement
Date:19-11-2020
Capital Allotment Shares
Category:Capital
Date:19-11-2020
Capital Allotment Shares
Category:Capital
Date:19-11-2020
Capital Allotment Shares
Category:Capital
Date:19-11-2020
Capital Allotment Shares
Category:Capital
Date:19-11-2020
Confirmation Statement With Updates
Category:Confirmation Statement
Date:10-06-2020
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:10-06-2020
Appoint Person Director Company With Name Date
Category:Officers
Date:04-06-2020
Capital Alter Shares Subdivision
Category:Capital
Date:30-03-2020
Incorporation Company
Category:Incorporation
Date:31-01-2020

Innovate Grants

6

This company received a grant of £286770.0 for Development Of A Novel Blood Test For The Early And More Accurate Diagnosis Of Pancreatic Cancer. The project started on 01/12/2022 and ended on 30/11/2025.

This company received a grant of £349790.0 for Clinical Verification Of A Novel Blood Test For More Accurate Ovarian Cancer Disease Monitoring. The project started on 01/07/2025 and ended on 30/06/2026.

+4 more grants available

Risk Assessment

low risk

International Score

Future Factor

excellent

Performance Rating

Accounts

Typemicro-entity accounts
Due Date31/10/2026
Filing Date29/10/2025
Latest Accounts31/01/2025

Trading Addresses

C/O Qubis Ltd, 63 University Road, Belfast, Bt7 1Nf, BT71NFRegistered
C/O Qubis Ltd, 63 University Road, Belfast, BT71NFRegistered
C/O Qubis Ltd, 63 University Road, Belfast, BT71NFRegistered

Contact

02890972566
C/O Qubis Ltd, 63 University Road, Belfast, BT71NF